KT&G Corp stock: U.S. fund builds stake as shares rally in Seoul

U.S. asset manager Capital Group has disclosed a 5.61% stake in KT&G Corp, adding to foreign buying pressure as the Korean tobacco stock trades near record highs.

KT&G Corp shares have drawn fresh attention from U.S. investors after Capital Group disclosed a 5.61% stake in the South Korean tobacco manufacturer, fueling a run of foreign buying that has pushed the stock toward record levels on the Korea Exchange.

According to a May 8, 2026, filing reported by PR Newswire as of May 8, 2026, The Capital Group Companies, Inc., a U.S.-based firm managing more than 3 trillion USD in assets, has acquired a 5.61% position in KT&G (KRX:033780). The move positions Capital Group among major foreign holders alongside BlackRock, First Eagle Investments and Singapore’s sovereign wealth fund GIC, all of which hold more than 5% of KT&G’s shares.

Foreign investors have extended their net buying streak in KT&G to 19 consecutive trading sessions through May 7, 2026, purchasing roughly 800,000 shares valued at about 140 billion KRW (around 100 million USD), according to the same filing. The share price has climbed above 180,000 KRW, reflecting strong demand from overseas funds despite the stock’s already elevated valuation multiples.

As of: 09.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: KT&G Corporation
• Sector/industry: Consumer non?cyclicals / tobacco
• Headquarters/country: South Korea
• Core markets: South Korea, Europe and international markets
• Key revenue drivers: Tobacco products, reconstituent tobacco sheets, red ginseng and health?food products
• Home exchange/listing venue: Korea Exchange (KRX:033780)
• Trading currency: South Korean won (KRW)

KT&G Corp: core business model

KT&G Corporation operates as South Korea’s leading tobacco manufacturer, producing, distributing and selling cigarettes and related products domestically and abroad. The company also manufactures reconstituent tobacco sheets used by other cigarette makers, giving it a dual role as both a branded player and a supplier to the global industry.

Beyond tobacco, KT&G has diversified into red ginseng, health?food products, beverages and cosmetics, aiming to reduce reliance on traditional cigarettes as smoking rates decline in many markets. This diversification strategy is designed to leverage the company’s brand strength and distribution network while tapping into growing consumer interest in wellness and functional foods.

For U.S. investors, KT&G offers exposure to a high?margin, cash?generating business in a regulated but still profitable sector, with a significant portion of earnings tied to the Korean domestic market and selective international operations.

Main revenue and product drivers for KT&G Corp

Tobacco remains KT&G’s primary revenue driver, with its domestic cigarette brands accounting for a large share of sales. The company has also expanded its global cigarette business, which contributed to a 27% increase in group operating profit in the first quarter of 2026, driven by a 56% rise in operating profit from the global cigarette segment, according to a May 2026 press release summarized by Barchart as of May 2026.

KT&G’s reconstituent tobacco sheet business adds another layer of profitability, as these sheets are sold to other manufacturers and benefit from stable demand and relatively high margins. The company’s red ginseng and health?food products, including functional foods and beverages, are positioned as higher?growth segments, though they still represent a smaller share of total revenue compared with tobacco.

Management has signaled plans to reinforce core competitiveness and introduce stronger shareholder return policies, including higher dividend payouts in the second half of 2026, which could further attract income?oriented investors despite the stock’s already rich valuation multiples.

Conclusion

KT&G Corp’s stock has attracted a notable stake from U.S. asset manager Capital Group, underscoring continued foreign interest in the Korean tobacco leader even as shares trade near record highs. The company’s strong first?quarter performance, driven by global cigarette growth and improved profitability, supports the current valuation but also raises questions about sustainability in a sector facing long?term regulatory and health pressures.

For U.S. investors, KT&G offers a way to access a cash?rich, dividend?oriented business in a non?U.S. market, with exposure to both domestic Korean demand and international cigarette operations. However, the stock’s elevated multiples and dependence on a highly regulated industry mean that investors should weigh potential returns against regulatory, currency and geopolitical risks.

This article does not constitute investment advice. Stocks are volatile financial instruments and past performance is not indicative of future results.